SURMODICS INC — Director's Dealing 2019

Feb 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-02-15

Reporting Person: Stich Joseph J. (VP and GM, IVD)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-15	Common Stock	S	600	$54.4367	Disposed	55894	Direct
2019-02-15	Common Stock	S	1103	$55.4169	Disposed	54791	Direct
2019-02-15	Common Stock	S	297	$56.297	Disposed	54494	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.

F2: Reflects the weighted average price of 600 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 15, 2019 with sale prices ranging from $54.08 to $55.01 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price of 1,103 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 15, 2019 with sale prices ranging from $55.08 to $56.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Reflects the weighted average price of 297 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 15, 2019 with sale prices ranging from $56.26 to $56.37 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.